(GSIW) Garden Stage Limited - Ratings and Ratios
Exchange: NASDAQ • Country: Hong Kong • Currency: USD • Type: Common Stock •
GSIW: Brokerage, Underwriting, Investment, Advisory, Asset Management
Garden Stage Limited, traded on the NASDAQ under the ticker GSIW, operates as a financial services provider in Hong Kong. Incorporated in 2022 and headquartered in Central, Hong Kong, the company specializes in securities dealing and brokerage services, underwriting and placing services, investment advisory services, and asset management, which includes discretionary account management and fund management. As a subsidiary of Oriental Moon Tree Limited, Garden Stage Limited leverages its parent companys resources while carving its niche in Hong Kongs competitive financial sector.
From a technical perspective, GSIWs stock exhibits a Last Price of $0.48, with a 20-day SMA of $0.50 and a 50-day SMA of $0.56, indicating recent price weakness relative to its short-term moving averages. The 200-day SMA stands at $3.44, suggesting significant long-term downside. The Average True Range (ATR) of $0.09 reflects low volatility, while the average 20-day volume of 206,477 shares highlights moderate liquidity.
Fundamentally, Garden Stage Limited has a market capitalization of $7.62 million USD, with a price-to-book (P/B) ratio of 1.13, signaling that investors are paying slightly above book value for each share. The price-to-sales (P/S) ratio of 5.80 indicates a premium valuation relative to its revenue. Notably, the return on equity (RoE) is exceptionally high at 291.18%, though this figure may be skewed by a small equity base. The absence of a P/E ratio suggests either minimal or negative earnings.
Additional Sources for GSIW Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GSIW Stock Overview
Market Cap in USD | 8m |
Sector | Financial Services |
Industry | Capital Markets |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception | 2023-12-01 |
GSIW Stock Ratings
Growth 5y | -52.5% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength | -95 |
Analysts | - |
Fair Price Momentum | 0.43 USD |
Fair Price DCF | - |
GSIW Dividends
No Dividends PaidGSIW Growth Ratios
Growth Correlation 3m | -67.2% |
Growth Correlation 12m | -88.8% |
Growth Correlation 5y | -89.1% |
CAGR 5y | -81.17% |
CAGR/Max DD 5y | -0.83 |
Sharpe Ratio 12m | -0.28 |
Alpha | -103.25 |
Beta | -0.872 |
Volatility | 142.91% |
Current Volume | 220.9k |
Average Volume 20d | 92k |
As of April 07, 2025, the stock is trading at USD 0.43 with a total of 220,932 shares traded.
Over the past week, the price has changed by -11.46%, over one month by -12.82%, over three months by -36.77% and over the past year by -94.66%.
No, based on ValueRay Analyses, Garden Stage Limited (NASDAQ:GSIW) is currently (April 2025) a stock to sell. It has a ValueRay Growth Rating of -52.54 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GSIW as of April 2025 is 0.43. This means that GSIW is currently overvalued and has a potential downside of 0%.
Garden Stage Limited has no consensus analysts rating.
According to ValueRays Forecast Model, GSIW Garden Stage Limited will be worth about 0.5 in April 2026. The stock is currently trading at 0.43. This means that the stock has a potential upside of +6.98%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 0.5 | 7% |